Loading company details...
Latest Form 4 (Oct 28, 2026): Alise Reicin (Chief Executive Officer): Exercise/Conversion of 10,000 shares, $23.8K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 28, 2026 | Alise Reicin, Chief Executive Officer | Exercise/Conversion | 10,000 | $23.8K |
| Oct 2, 2026 | Daniel Lochner, Chief Financial Officer | Tax Withholding | 520 | $12.3K |
| Oct 2, 2026 | Peter McNamara, Chief Scientific Officer | Tax Withholding | 444 | $10.5K |
| Oct 2, 2026 | Marcella K. Ruddy, Chief Medical Officer | Tax Withholding | 525 | $12.4K |
| Oct 2, 2026 | Alise Reicin, Chief Executive Officer | Tax Withholding | 1,545 | $36.6K |
| Oct 2, 2026 | Marc Schwabish, Chief Business Officer | Tax Withholding | 411 | $9.7K |
| Sep 8, 2026 | Marc Schwabish, Chief Business Officer | Grant/Award | 17,750 | n/a |
| Sep 8, 2026 | Peter McNamara, Chief Scientific Officer | Grant/Award | 21,000 | n/a |
| Sep 8, 2026 | Daniel Lochner, Chief Financial Officer | Grant/Award | 24,250 | n/a |
| Sep 8, 2026 | Marcella K. Ruddy, Chief Medical Officer | Grant/Award | 24,250 | n/a |